Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Neoplastic Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04162327
What this trial is testing

A Phase Ia/Ib Study of IBI315 in Patients With HER2-expressing Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumor
Innovent Biologics (Suzhou) Co. Ltd. 55
Testing effectiveness (Phase 2)Ended earlyNCT00836927
What this trial is testing

Extension Trial of Deforolimus (Ridaforolimus, MK-8669) in Participants With Advanced Cancer (MK-8669-038)

Who this might be right for
Advanced Cancers
Merck Sharp & Dohme LLC 7
Large-scale testing (Phase 3)Looking for participantsNCT06338683
What this trial is testing

Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer

Who this might be right for
Advanced CancerOlanzapineProgression Free Survival
Qinghai Red Cross Hospital 230
Large-scale testing (Phase 3)UnknownNCT03927456
What this trial is testing

SHR6390 in Combination With Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
Jiangsu HengRui Medicine Co., Ltd. 357
Early research (Phase 1)Study completedNCT04773951
What this trial is testing

A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JS004 in Advanced Solid Tumors

Who this might be right for
MelanomaRenal CarcinomaUrothelial Carcinoma
Shanghai Junshi Bioscience Co., Ltd. 47
Early research (Phase 1)Study completedNCT05327231
What this trial is testing

IN10018 Monotherapy or in Combination With Docetaxel in Gastric or GEJ Adenocarcinoma

Who this might be right for
Gastric Cancer
InxMed (Shanghai) Co., Ltd. 33
Early research (Phase 1)Study completedNCT00555672
What this trial is testing

Study Of Sunitinib In Combination With Cisplatin And 5-Fluorouracil In Patients With Advanced Gastric Cancer

Who this might be right for
Stomach Neoplasms
Pfizer 34
Not applicableUnknownNCT04520295
What this trial is testing

CtDNA Screening in Advanced HER2 Positive Gastric Cancer

Who this might be right for
HER2-positive Gastric Cancer
Ruijin Hospital 100
Testing effectiveness (Phase 2)Looking for participantsNCT05405595
What this trial is testing

ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced/Metastatic Solid Tumors
Adagene Inc 186
Testing effectiveness (Phase 2)Study completedNCT01924195
What this trial is testing

Phase II Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0302）

Who this might be right for
Non-small Cell Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 117
Testing effectiveness (Phase 2)UnknownNCT05934539
What this trial is testing

ALG.APV-527 First-in-human Study

Who this might be right for
Solid Tumor
Aptevo Therapeutics 56
Early research (Phase 1)Ended earlyNCT01739439
What this trial is testing

Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by Surgery

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasStage IIB Pancreatic Cancer+1 more
Fox Chase Cancer Center 6
Testing effectiveness (Phase 2)Looking for participantsNCT07448077
What this trial is testing

Short-course Radiotherapy in TNT Combined With Enlonstobart for pMMR LARC

Who this might be right for
Efficacy and Safety of Short-course Radiotherapy in Total Neoadjuvant Therapy Combined With Enlonstobart for pMMR Locally Advanced Rectal Cancer
Hebei Medical University Fourth Hospital 128
Testing effectiveness (Phase 2)UnknownNCT04204577
What this trial is testing

The Safety and Efficacy of Thermal Ablation Combined With Apatinib and Carilimub for Advanced Liver Cancer

Who this might be right for
BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular Carcinoma
Chinese PLA General Hospital 90
Not applicableStudy completedNCT02558257
What this trial is testing

Perception of Palliative Care Encounter

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 209
Testing effectiveness (Phase 2)Looking for participantsNCT05579366
What this trial is testing

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Who this might be right for
High Grade Epithelial Ovarian CancerHigh Grade Serous Ovarian CancerPrimary Peritoneal Carcinoma+12 more
Genmab 884
Testing effectiveness (Phase 2)Study completedNCT00052429
What this trial is testing

High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer

Who this might be right for
Head and Neck Cancer
Memorial Sloan Kettering Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT02002312
What this trial is testing

Phase II Study of Lutetium-177 Labeled Girentuximab in Patients With Advanced Renal Cancer

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
Radboud University Medical Center 14
Testing effectiveness (Phase 2)Ended earlyNCT05110781
What this trial is testing

Atezolizumab Before Surgery for the Treatment of Regionally Metastatic Head and Neck Squamous Cell Cancer With an Unknown or Historic Primary Site

Who this might be right for
Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and NeckResectable Cutaneous Squamous Cell Carcinoma of the Head and NeckStage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
University of California, Davis 1
Testing effectiveness (Phase 2)Study completedNCT01054781
What this trial is testing

Intensified 1st Cycle Rituximab Plus 8th Cycles of R-CHOP Chemotherapy in Patients With Advanced or Bulky CD20+ Diffuse Large B-cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-cell Lymphoma (DLBCL)
Samsung Medical Center 91
Next Page